ctrl K

Translational Development... (TDACU)

10.20

0.00 (0.00%)

At close: Apr 25, 2025, 3:59 PM

10.20

0.00%

After-hours: Apr 25, 2025, 04:00 PM EDT

Translational Development Acquisition Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	438.17K	2.02K	2.23K
Short-Term Investments	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a
Other Long-Term Assets	174.35M	n/a	383.01K
Receivables	n/a	n/a	n/a
Inventory	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a
Total Current Assets	650.23K	2.02K	54.23K
Property-Plant & Equipment	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a
Total Long-Term Assets	174.35M	n/a	383.01K
Total Assets	175M	2.02K	437.24K
Account Payables	16.19K	n/a	n/a
Deferred Revenue	n/a	n/a	n/a
Short-Term Debt	n/a	347.5K	259K
Other Current Liabilities	194.11K	n/a	n/a
Total Current Liabilities	210.3K	509.68K	459.39K
Long-Term Debt	n/a	n/a	n/a
Other Long-Term Liabilities	6.04M	n/a	-50
Total Long-Term Liabilities	6.04M	n/a	-50
Total Liabilities	6.25M	509.68K	459.34K
Total Debt	n/a	347.5K	259K
Common Stock	18.33B	466.00	466.00
Retained Earnings	-5.6M	-532.66K	-47.11K
Comprehensive Income	16.88B	n/a	n/a
Shareholders Equity	168.75M	-507.66K	-22.11K
Total Investments	174.35M	n/a	n/a